The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases
Phase 1 1 Study Assesing the Benefit of Pasteurized Goat Milk in Reducing Disease Severity of Young Children With Oral Ulcer Diseases
1 other identifier
interventional
65
1 country
1
Brief Summary
Children with acute diseases with oral ulcers (not included PRESENTATIONS OF SLE, IBD or IMMUNOCOMPRMIZED STATES)will receive several doses (drinking or mouth rinsing) of either pasteurized goat milk or cow milk. Children will than be followed for length of the disease - signs and symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jan 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 13, 2006
CompletedFirst Posted
Study publicly available on registry
June 6, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedSeptember 4, 2009
September 1, 2009
1.9 years
January 13, 2006
September 3, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Severity of disease
3 years
Length of disease
3 years
Study Arms (2)
1
EXPERIMENTAL55 children \< 5 years with acute oral ulcer disease.
2
PLACEBO COMPARATOR55 Children \< 5 years with acute oral ulcer disease.
Interventions
Eligibility Criteria
You may qualify if:
- Age \> 6 months or \< 5 years.
- Acute (\< 48 hours) oral ulcer disease.
- \> 5 ulcers.
- Cooperative parents .
- Signing inform consent.
You may not qualify if:
- All types of immunosuppression, IBD, SLE, recurrent oral ulcer, disease \> 48 hours, age , 6 \< months or \> 5 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dan Miron
Afula, 18101, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dan Miron, MD
HaEmek Medicak Center, Afula, Israel
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 13, 2006
First Posted
June 6, 2006
Study Start
January 1, 2006
Primary Completion
December 1, 2007
Study Completion
December 1, 2007
Last Updated
September 4, 2009
Record last verified: 2009-09